A detailed history of Pender Fund Capital Management Ltd. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Pender Fund Capital Management Ltd. holds 580,300 shares of MRVI stock, worth $1.82 Million. This represents 2.18% of its overall portfolio holdings.

Number of Shares
580,300
Holding current value
$1.82 Million
% of portfolio
2.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$4.42 - $8.5 $2.56 Million - $4.93 Million
580,300 New
580,300 $3.16 Million
Q2 2022

Aug 15, 2022

BUY
$26.05 - $37.48 $31,260 - $44,975
1,200 New
1,200 $44,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $413M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Pender Fund Capital Management Ltd. Portfolio

Follow Pender Fund Capital Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pender Fund Capital Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Pender Fund Capital Management Ltd. with notifications on news.